Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease

Posted on August 12, 2021 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.